AYTU All Time Low | Fast Track Designation form FDA today

19 thg 4, 2022

AYTU Aytu BioPharma announced today that the FDA has granted Fast Track designation to AR101, a protein kinase inhibitor, for the treatment of patients with Vascular Ehlers-Danlos Syndrome.

After the bullish news, AYTU stock hit the all time low level.
52 Week Range 0.76 - 7.20
LADENBURG THALM has a price target of $14.50 for the stock.

I think a reversal is imminent.
My price target is $5.25.

Looking forward to read your opinion about it.